| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,823 |
5,344 |
$896K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,195 |
1,625 |
$463K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,333 |
1,140 |
$455K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
536 |
413 |
$234K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,910 |
592 |
$171K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,589 |
4,084 |
$162K |
| 80053 |
Comprehensive metabolic panel |
4,118 |
3,438 |
$146K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
731 |
702 |
$133K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,819 |
3,695 |
$112K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
878 |
706 |
$85K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,097 |
2,534 |
$78K |
| J3490 |
Unclassified drugs |
3,605 |
1,669 |
$74K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
622 |
174 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,181 |
2,618 |
$68K |
| 36415 |
Collection of venous blood by venipuncture |
6,020 |
4,854 |
$59K |
| 71046 |
Radiologic examination, chest; 2 views |
308 |
284 |
$35K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,044 |
958 |
$33K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
250 |
231 |
$30K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
302 |
255 |
$29K |
| 87631 |
|
357 |
307 |
$26K |
| 85027 |
|
1,452 |
1,309 |
$25K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
218 |
138 |
$25K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
15 |
12 |
$24K |
| 87088 |
|
874 |
745 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
233 |
188 |
$21K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
405 |
300 |
$20K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
212 |
179 |
$17K |
| 81003 |
|
1,284 |
1,142 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
317 |
287 |
$16K |
| 81001 |
|
995 |
857 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
81 |
13 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
148 |
139 |
$11K |
| 84484 |
|
249 |
185 |
$11K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
343 |
237 |
$10K |
| 80061 |
Lipid panel |
279 |
253 |
$10K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
217 |
81 |
$10K |
| 90834 |
Psychotherapy, 45 minutes with patient |
81 |
36 |
$9K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
133 |
99 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
75 |
59 |
$7K |
| 83735 |
|
558 |
465 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
193 |
171 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
271 |
246 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
96 |
92 |
$7K |
| 86140 |
|
162 |
131 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
144 |
121 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
54 |
54 |
$5K |
| 81025 |
|
139 |
131 |
$5K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
888 |
479 |
$4K |
| 80306 |
|
42 |
39 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
85 |
80 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
182 |
142 |
$4K |
| 84145 |
|
85 |
57 |
$4K |
| 97161 |
|
55 |
53 |
$3K |
| A9270 |
Non-covered item or service |
251 |
43 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
48 |
44 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
48 |
44 |
$3K |
| 97164 |
|
74 |
70 |
$2K |
| 90686 |
|
276 |
274 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
340 |
247 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
41 |
41 |
$2K |
| 97168 |
|
40 |
38 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
338 |
256 |
$2K |
| 87400 |
|
16 |
14 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
442 |
358 |
$2K |
| 84439 |
|
43 |
38 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
15 |
15 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14 |
14 |
$1K |
| 87077 |
|
66 |
56 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
31 |
27 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$1K |
| 87186 |
|
49 |
41 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
241 |
195 |
$870.89 |
| 83690 |
|
15 |
13 |
$740.74 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
48 |
39 |
$728.34 |
| Q3014 |
Telehealth originating site facility fee |
13 |
12 |
$318.85 |
| 90656 |
|
16 |
16 |
$233.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
27 |
$232.25 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
27 |
24 |
$144.71 |
| 90685 |
|
13 |
13 |
$139.23 |
| 90670 |
|
13 |
13 |
$131.04 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
33 |
26 |
$129.92 |
| G0008 |
Administration of influenza virus vaccine |
128 |
128 |
$0.00 |